MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc ... receptor and µ-opioid peptide (MOP) receptor (dual-NMR) agonism. This dual-NMR agonist has the potential to deliver significant ...